Winter fish anti-water mildew

In the winter and early spring, it is the season of stocking fish. In the process of pulling or transporting fish, if the fish is injured due to improper operation, the fish will be infected with water fungus.

Susceptible fish, the surface of the wounded body covered with cotton wool like water mold mycelium; sick fish anxiety, movement disorders, increased mucus in the skin, loss of appetite, and finally died of weakness.

In winter and spring, the water-proof mildew is firstly based on prevention. When stocking fish or wintering in ponds, during the process of netting, turning, transportation and stocking, the operation should be light and care should be taken to avoid injury to the fish. Before the fish species are stocked, 100 kilograms of lime are used per acre pond. After the water is discharged, clear ponds and disinfection are performed evenly in the whole pool, which can significantly reduce the probability of occurrence of this disease.

Winter fish water mildew, followed by timely treatment. The original malachite green used to prevent and control fishy hydromycosis has been a banned drug. Fishermen can use the following prevention and control measures: fish species ponds with 3 ~ 5% of salt water before soaking fish species for 5 to 10 minutes. Each mu of water depth of 1 meter water surface, with 2.5 kg of madder grass, 0.5 kg of black wolfberry fruit, 2 kg of maple leaves mixed with Jianzhi, juice diluted with water and Quanchiposa, splashed once a day, even splashed 2 to 3 days . Each mu of water depth of 1 meter of water, with 5 kg of calamus juice, 1 kg of salt, add 20 kg of human urine mixed evenly, after the water Quanchiposa.

Ibrutinib is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK) that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia, a form of non-Hodgkin's lymphoma.
Ibrutinib is used to treat chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, and marginal zone lymphoma.
We produce a series of complete intermediates for Ibrutinib, intermediate I (CAS No. 330786-24-8) and intermediate II (CAS No. 143900-44-1) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.

Ibrutinib Intermediates

Ibrutinib Intermediates,Cas 330786-24-8,Cas 143900-44-1,High Purity Ibrutinib Intermediates

Nanjing Sunshine Biotech Co., Ltd , http://www.sunshine-bio.com